CHALLENGER LIMITED (CGF)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

CGF - CHALLENGER LIMITED

FNArena Sector : Wealth Management & Investments
Year End: June
GICS Industry Group : Diversified Financials
Debt/EBITDA: N/A
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

Challenger Ltd is an Australian financial company that specialises in superannuation and annuities. It claims to be Australia's largest guaranteed income provider. Founded in 1985 it was listed in 2003.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$6.13

17 Jan
2025

0.040

OPEN

$6.08

0.66%

HIGH

$6.16

503,098

LOW

$6.07

TARGET
$7.571

-0.04 change from previous day

 23.5% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
AEF . AMP . ASX . AVC . BVS . CVW . DJW . ENN . GDC . GDG . GQG . HMC . HUB . IFL . IFT . IRE . KAM . KSL . MAF . MFG . MQG . NGI . NWL . PAC . PNI . PPS . PPT . PTM . QAL . RPL . RZI . WHF .
FNARENA'S MARKET CONSENSUS FORECASTS
CGF: 1
Title FY23
Actual		 FY24
Actual		 FY25
Forecast		 FY26
Forecast
EPS (cps) xxx 19.0 59.5 xxx
DPS (cps) xxx 26.5 27.9 xxx
EPS Growth xxx - 55.0% 100.0% xxx
DPS Growth xxx 10.4% 5.4% xxx
PE Ratio xxx N/A 10.2 xxx
Dividend Yield xxx N/A 4.6% xxx
Div Pay Ratio(%) xxx 139.6% 46.9% xxx

Dividend yield today if purchased 3 years ago: 4.35%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 4.35

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 26/08 - ex-div 13.50c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx19.0
DPS All xxxxxxxxxxxxxxx26.5
Sales/Revenue xxxxxxxxxxxxxxx2,907.7 M
Book Value Per Share xxxxxxxxxxxxxxx568.0
Net Operating Cash Flow xxxxxxxxxxxxxxx843.7 M
Net Profit Margin xxxxxxxxxxxxxxx4.63 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx3.35 %
Return on Invested Capital xxxxxxxxxxxxxxx2.45 %
Return on Assets xxxxxxxxxxxxxxx0.42 %
Return on Equity xxxxxxxxxxxxxxx3.35 %
Return on Total Capital xxxxxxxxxxxxxxx11.14 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx692.4 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx5,593 M
Long Term Debt xxxxxxxxxxxxxxx1,532 M
Total Debt xxxxxxxxxxxxxxx7,126 M
Goodwill - Gross xxxxxxxxxxxxxxx580 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx573 M
Price To Book Value xxxxxxxxxxxxxxx1.23

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx1.9 M
Capex % of Sales xxxxxxxxxxxxxxx0.07 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx828 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx31,000 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.9

No. Of Recommendations

7
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Bell Potter

18/10/2024

1

Re-initiation with Buy

$8.25

34.58%

Bell Potter re-initiates coverage of Challenger with a Buy rating and $8.25 target.

The positive stance is based on the increasing trend in sales of lifetime annuities and the corresponding growth in Challenger's life book.

The broker believes the most important product for the company is lifetime annuities and explains how lifetime sales have increased again, generating over $200m per quarter and rising to $275m in 1Q25 as the interest rate backdrop has normalised post covid.

Bell Potter forecasts the life book will revert to high-single or low-double digit growth as lifetime annuities pick up.

FORECAST
Bell Potter forecasts a full year FY25 dividend of 30.30 cents and EPS of 65.90 cents.
Bell Potter forecasts a full year FY26 dividend of 31.60 cents and EPS of 68.70 cents.

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Goldman Sachs

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Jarden

16/01/2025

2

Overweight

$7.70

25.61%

Jarden marks-to-market earnings forecasts for five stocks in the broker's wealth management coverage for the December 2024 quarter.

The changes reflect negative Australian equity market returns offset by positive international equity returns.

Jarden lowers EPS forecasts for Challenger by -2.2% in FY25 and -1.5% in FY26 due to changes in life margin assumptions.

The stock is Overweight rated, with the analyst highlighting "compelling" value and potential upside from higher interest rates and annuity sales.

The target price is lowered to $7.70 from $8.10.

FORECAST
Jarden forecasts a full year FY25 dividend of 26.10 cents and EPS of 60.00 cents.
Jarden forecasts a full year FY26 dividend of 27.90 cents and EPS of 65.00 cents.
Access Extra Coverage Research History >

CGF STOCK CHART

FNArena News on CGF

1
Australian Broker Call *Extra* Edition – Jan 16, 2025

Jan 16 2025 - Daily Market Reports
2
Next Week At A Glance – 9-13 Dec 2024

Dec 06 2024 - Weekly Reports
3
Rudi’s View: A Cautious Preview Into 2025

Dec 04 2024 - Rudi's View
4
Rudi’s View: Australia’s Most Highly Recommended Stocks

Oct 23 2024 - Rudi's View
5
Australian Broker Call *Extra* Edition – Oct 22, 2024

Oct 22 2024 - Daily Market Reports

Latest Wealth Management & Investments News

1
Monthly Listed Investment Trust Report – Dec 2024

Dec 18 2024 - Australia
2
Weekly Update On LICs & LITs – 17-Dec-2024

Dec 17 2024 - Weekly Reports
3
GQG Partners Shrugs Off Adani

Dec 13 2024 - Small Caps
4
Generation Development, The Next Hub24?

Dec 12 2024 - Small Caps
5
Weekly Update On LICs & LITs – 10-Dec-2024

Dec 10 2024 - Weekly Reports
6
Weekly Update On LICs & LITs – 03-Dec-2024

Dec 03 2024 - Weekly Reports
7
Weekly Update On LICs & LITs – 26-Nov-2024

Nov 26 2024 - Weekly Reports
8
Weekly Update On LICs & LITs – 19-Nov-2024

Nov 19 2024 - Weekly Reports
9
Weekly Update On LICs & LITs – 12-Nov-2024

Nov 12 2024 - Weekly Reports
10
Australian Listed Investment Company Report – Nov 2024

Nov 11 2024 - Australia